Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled trial
Factors such as stress, sodium intake, hormonal changes, poor sleep, travel, and exercise can all cause temporary water retention
Future human studies will help us to better understand the big picture of this relationship, to hopefully provide mechanistic knowledge upon which new treatments could be created, such as microbiome-directed gene-therapies for the management of metabolic diseases
Interactions with Medications: Vitamin B12 has the potential to interact with certain medications, including diabetic prescriptions, metformin, proton pump inhibitors, antagonists and antibiotics
Tirzepatide's dual GIP/GLP-1 mechanism works independently of estrogen levels
US$ 20.31
US$ 27.56
US$ 20.47
US$ 27.72
US$ 23.64
US$ 27.82
